Connect with us
Farmaindustria’s 2025 report shows 82% of Spanish pharmaceutical companies apply circular economy strategies, with 80% using renewable energy and saving 1,700 tons of packaging yearly. The...
More than 60% of the €1.27 billion allocated to R&D in 2021 was devoted to clinical trials (€789 million), where Spain plays a prominent international role,...
Spain become one of the countries with the best conditions to host the research and development of new medicine. To the point that Spanish doctors and...